Seeking Alpha

Vertex (VRTX -1.4%) dips on an earlier downgrade to Neutral at Credit Suisse, citing lower sales...

Vertex (VRTX -1.4%) dips on an earlier downgrade to Neutral at Credit Suisse, citing lower sales forecasts for Incivek given Gilead (GILD) new competition and expectations for significant warehousing pressure on margins. The firm also lowers its price target to $48 from $56.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)